Welcome
Support Centre
12 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Very Early Rehabilitation or Intensive Telemetry After Stroke (VERITAS)
ISRCTN ISRCTN23817752
ClinicalTrials.gov identifier
Public title Very Early Rehabilitation or Intensive Telemetry After Stroke (VERITAS)
Scientific title Very Early Rehabilitation or Intensive Telemetry After Stroke (VERITAS): a pilot randomised controlled trial
Acronym VERITAS
Serial number at source 05/MRE00/90
Study hypothesis Very early rehabilitation or intensive monitoring will reduce complications and improve patient recovery after stroke.
Lay summary
Ethics approval Ethics Committee Scotland (A) MREC. Date of approval: 22/12/2005 (ref: 05/MRE00/90)
Study design Single-blind, factorial (2 x 2) pilot randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Acute stroke
Participants - inclusion criteria Individuals (both males and females) admitted to hospital with symptoms of new stroke within 24 hours of symptom onset (with the primary objective of recruiting individuals within 12 hours of symptom onset).
Participants - exclusion criteria 1. Individuals with severe pre-stroke disability
2. Those who have made a full recovery
3. Severe comorbidities which would prevent their participation in the trial
Anticipated start date 01/03/2007
Anticipated end date 01/02/2008
Status of trial Completed
Patient information material
Target number of participants 20
Interventions The participants were randomly allocated to the following four arms:

1. Standard care: Early transfer to an established multidisciplinary stroke unit where they will receive conventional stroke unit care within an established stroke service

2. Early mobilisation plus standard care: The early mobilisation interventions are based on the AVERT trial (see below), and will begin within 24 hours of the onset of the symptoms. The protocol is functional and task specific and can be summarised as follows:
a. Mobilisation should commence as soon as possible on the stroke unit
b. Bedrest should be avoided if at all possible
c. Patients will be encouraged to be up, sitting and transferring at least 4 times per day
d. Any vulnerable hemioplegic shoulder will be cared for using supports when sitting, transferring and walking

The primary objective is to increase the frequency of mobilisation. The protocol will be delivered by the research nurse, under the supervision of a trained physiotherapist. During the first 3 days after stroke the stroke patients will be observed closely for abnormalities of heart rate, oxygen saturation and blood pressure during mobilisation. If there are any abnormalities during these procedures, mobilisation will be discontinued. The five stages for monitoring are as follows:
i. Before mobilisation (lying in bed)
ii. Sitting upright in bed
iii. Sitting on the edge of the bed
iv. After five minutes sitting on the edge of the bed
v. After transferring to a chair

The duration of each early mobilisation intervention will be determined by the patient tolerance but will range between 5 and 30 minutes per session. The research nurse trained in the intervention will be available on the ward during weekdays as will be supervising physiotherapist. The intervention will continue for at least 7 days or until discharge whichever is sooner.

3. Automated physiological monitoring: Standard care plus a protocol based on the Gateshead trial (see below) guiding the continuous monitoring. This will use an established commercial system (Welch Allyn Inc), which will include the possibility of ambulatory monitoring. The protocol will include advice on responding to abnormalities of heart rate or rhythm, blood pressure, temperature, oxygen level or blood glucose. Routine monitoring will be continued for the first three days and extended beyond then if persisting abnormalities are identified. After this time patients will revert to standard care. The research nurse will devote time to ensuring the monitoring protocol is followed.

4. A combined protocol incorporating both 2 and 3 above

Total duration of interventions: 1 week
Total duration of follow-up: 3 months

Information on the AVERT trial can be found at http://www.ncbi.nlm.nih.gov/pubmed/18706042

Information on the Gateshead trial can be found in the 1998 British Geriatrics Society autumn meeting abstract (http://www.ncbi.nlm.nih.gov/pubmed/10450456) - Davis M, Hollyman C, McGiven M, Chambers I, Egbuji J, Barer D. Physiological monitoring in acute stroke. Age Ageing 1999 (Suppl):P33
Primary outcome measure(s) The following will be monitored for 7 days:
1. Feasibility (especially treatment contamination)
2. Acceptability of the trial process
3. Safety of the trial process: early complications and adverse events

Note: The primary outcome of the proposed main trial will be the proportion of patients dead or disabled (Modified Rankins Score 3-5) at 3 months post stroke.
Secondary outcome measure(s) Patient activity, recorded for 7 days using automated activity monitors which record the time spent lying, sitting, standing or walking.
Sources of funding Chest, Heart and Stroke Scotland (Ref: 05/A87)
Trial website
Publications
Contact name Prof  Peter  Langhorne
  Address Academic Section of Geriatric Medicine
Level 3, University Block
Royal Infirmary
  City/town Glasgow
  Zip/Postcode G31 2ER
  Country United Kingdom
Sponsor Greater Glasgow and Clyde NHS Board (UK)
  Address East Research Office
Glasgow Royal Infirmary
4th Floor Walton Building
84 Castle Street
  City/town Glasgow
  Zip/Postcode G4 0SF
  Country United Kingdom
  Sponsor website: http://www.nhsggc.org.uk
Date applied 27/08/2008
Last edited 30/09/2008
Date ISRCTN assigned 30/09/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central